Is U.S. Physical Therapy (USPH) a Hidden Gem in the Undervalued Healthcare Sector?
In the ever-evolving healthcare sector, where margins are razor-thin and regulatory headwinds loom large, U.S. Physical Therapy, Inc. (USPH) stands...
Healthcare and Therapy
ChatGPT is banned in this US states along with other AI bots: The reason will make you rethink AI in healthcare |
The rise of AI in healthcare is inevitable, but its role must be clearly defined and carefully regulated. Illinois has...
Medical acupuncture in healthcare: nurse perspectives and implementation
This article explores how nurses trained in Western medical acupuncture are integrating the practice into symptom management in cancer and...
The healing power of touch: The benefits of massage therapy
The University of Kentucky Public Relations and Strategic Communications Office provides a weekly health column available for use and reprint...
Patient-reported quality of outpatient healthcare in patients with chronic back or arthrosis pain with long-term opioid therapy in Germany | BMC Primary Care
The cross-sectional survey cohort comprised 661 individuals insured by “DAK-Gesundheit” with long-term opioid therapy and chronic back and/or arthrosis pain....
Assessing quality of health care in the context of patient satisfaction from patients’ perspective among a physical therapy and rehabilitation unit | BMC Health Services Research
Recently by the improvement process of health care delivery system the rising star is patient’s opinion. Patient satisfaction is the...
Recommended Hydration IV Therapy in NJ
Doxwel IV Therapy Lounge & MedSpa is a family-owned and operated venture that utilizes highly trained clinicians and innovative technology...
Intelligent Healthcare Therapy Solutions Market 2025-2032
Intelligent Healthcare Therapy Solutions MarketThe Intelligent Healthcare Therapy Solutions industry is rapidly evolving, driven by advancements in AI, machine learning,...
FDA Delays Approval of Replimune’s Melanoma Therapy Despite Promising Trial Results
For now, the FDA has denied approval today of a new melanoma treatment developed by Replimune. The company’s lead drug...
